Skip to content

Released Mar 2, 2017, after the close

10-K filed Mar 3, 2017, 62 days after period end · 0001628280-17-002137

Q4 2016 · 10-K
Revenue$25.08M−18.4% vs Q4 2015+13.0% vs Q3 2016
Net Income-$17.70MderivedN/M vs Q4 2015N/M vs Q3 2016
EPS Diluted-$0.61N/M vs Q4 2015N/M vs Q3 2016
Operating Incomederived-$17,696,000N/M
Operating Cash Flowderived-$10,730,000N/M
Free Cash Flowderived-$11,424,000N/M
Margins · derived
Operating margin-70.5%−26.0 pt vs Q4 2015
Net margin-70.5%−28.6 pt vs Q4 2015

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2016Q4 2015Q4 2014Q4 2013
Revenue$25.08M$30.72M$33.49M$20.88M
Net Income-$17.70M-$12.88M-$10.94M-$4.64M
EPS Diluted-$0.61-$0.45-$0.39-$0.18

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR